L03RD2
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for L03RD2, covering 2025-11-21 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers [Phase 1]